![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/GVBL.png)
Share the post "Shareholding Pattern: Shareholding Pattern Genomic Valley Biotech FY(Q2-Sep 2024-2025)"
Genomic Valley Biotech has released its latest shareholding reports, covering the Second quarter and the fiscal year ending on (Q2-Sep 2024-2025).This detailed report examines who owns shares, including Promoters, promoter groups, Foreign investors, public investors, and government entities.
| Shareholder Name | Previous Quater Quantity(In Crores) | Current Quater Quantity(In Crores) | Previous Quater Shares(in %) | Current Quater Shares(in %) | Quater to Quater Difference |
|---|---|---|---|---|---|
| Promoters | 0.20 | 0.17 | 64.14 | 54.67 | -9.47 % |
| Public | 0.11 | 0.14 | 35.86 | 45.33 | +9.47 % |
| DII | 0 | 0 | 0 | 0 | 0 |
| FII | 0 | 0 | 0 | 0 | 0 |
| Government | 0 | 0 | 0 | 0 | 0 |
Promoters’ shareholding decreased from 64.14% in June 2024 to 54.67% in September 2024. This reduction indicates that the promoters’ control over Company has weakened during this period.The percentage of shares held by the public increased from 35.86% in June 2024 to 45.33% in September 2024.This change suggests that the public’s investment in the company grew during the quarter.
Let’s look into the statistics of the investors, which could have contributed to the fluctuations in the shareholding pattern.
| Shareholder Name | Previous Quarter Quantity (In crores) | Current Quarter Quantity (In crores) | Previous Quarter Shares (in %) | Current Quarter Shares (in %) | Quarter-to-Quarter Difference (%) |
|---|---|---|---|---|---|
| Parul Agrawal | 0.028 | 0.012 | 9.29 | 3.91 | -5.38 % |
| Yogesh Agrawal | 0.167 | 0.155 | 54.78 | 50.7 | -4.08 % |
Parul Agrawal faced a downturn in stakeholding this quarter, witnessing a decline of -5.38 % in stakeholding compared to the previous quarter.Yogesh Agrawal faced a downturn in stakeholding this quarter, witnessing a decline of -4.08 % in stakeholding compared to the previous quarter.
| Shareholder Name | Previous Quarter Quantity (In Crores) | Current Quarter Quantity (In Crores) | Previous Quater Shares (in %) | Current Quater Shares (in %) | Quater-to-Quater Difference (%) |
|---|---|---|---|---|---|
| Resident Individuals holding nominal share capital up to Rs. 2 lakhs | 0.029 | 0.062 | 9.46 | 20.38 | + 10.92 % |
| Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs | 0.078 | 0.074 | 25.6 | 24.36 | -1.24 % |
| Harish Chandra Sharma | 0.015 | 0.009 | 4.81 | 2.87 | -1.94 % |
| Non Resident Indians (NRIs) | 0.001 | 0.000 | 0.2 | 0.11 | -0.09 % |
| Any Other (specify) | 0.002 | 0.001 | 0.57 | 0.45 | -0.12 % |
| HUF | 0.002 | 0.001 | 0.57 | 0.45 | -0.12 % |
Leading the way to higher stakeholding, Resident Individuals holding nominal share capital up to Rs. 2 lakhs has significantly boosted stakeholding by an impressive 10.92 %.Observations show a significant difference of -1.24 % in Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs’s financial performance between quarters.Observations show a significant difference of -1.94 % in Harish Chandra Sharma’s financial performance between quarters.Observations show a significant difference of -0.09 % in Non Resident Indians (NRIs)’s financial performance between quarters.Observations show a significant difference of -0.12 % in Any Other (specify)’s financial performance between quarters.Observations show a significant difference of -0.12 % in HUF’s financial performance between quarters.
[my_shortcode1 values=”Genomic Valley Biotech”]
